株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のオピオイド市場規模、シェア、動向分析:製品別、用途別(疼痛緩和、麻酔、咳止め、下痢止め、依存症治療)、地域動向、セグメント予測

Opioids Market Size, Share & Trends Analysis Report By Product (IR/ Short-acting, ER/Long-acting), By Application (Pain Relief, Anesthesia), By Region, And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 640073
出版日 ページ情報 英文 113 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.78円で換算しております。
Back to Top
世界のオピオイド市場規模、シェア、動向分析:製品別、用途別(疼痛緩和、麻酔、咳止め、下痢止め、依存症治療)、地域動向、セグメント予測 Opioids Market Size, Share & Trends Analysis Report By Product (IR/ Short-acting, ER/Long-acting), By Application (Pain Relief, Anesthesia), By Region, And Segment Forecasts, 2019 - 2026
出版日: 2019年04月09日 ページ情報: 英文 113 Pages
概要

当レポートでは、世界のオピオイド市場について調査し、市場の現状と成長予測、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、範囲

  • 市場セグメンテーションと範囲
  • 市場促進因子
  • 市場阻害因子
  • 浸透と成長見通しマッピング
  • SWOT分析
  • 業界分析

第4章 タイプ別予測と動向分析

  • 動向分析
  • 即効型/短期作用型オピオイド
  • 徐放型/長期作用型オピオイド

第5章 用途別予測と動向分析

  • 動向分析
  • 疼痛緩和
  • 麻酔
  • 咳止め
  • 下痢止め
  • 依存症治療

第6章 地域別市場

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合環境

  • 戦略枠組み
  • 市場参入分類
  • 企業プロファイル
    • Purdue Pharma L.P.
    • Janssen Pharmaceuticals, Inc.
    • West-Ward Pharmaceuticals Corporation
    • Pfizer, Inc.
    • Allergan Plc (Actavis)
    • Sanofi-Aventis S.A.
    • Sun Pharmaceutical Industries Limited
    • Egalet Corporation
図表

List of Tables

  • TABLE 1 Country Share Estimation
  • TABLE 2 North America Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 3 North America IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 4 North America IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 5 North America ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 6 North America ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 7 North America Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 8 North America Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 9 U.S. Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 10 U.S. IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 11 U.S. IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 12 U.S. ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 13 U.S. ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 14 U.S. Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 15 U.S. Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 16 Canada Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 17 Canada IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 18 Canada IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 19 Canada ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 20 Canada ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 21 Canada Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 22 Canada Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 23 Europe Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 24 Europe IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 25 Europe IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 26 Europe ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 27 Europe ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 28 Europe Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 29 Europe Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 30 U.K. Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 31 U.K. IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 32 U.K. IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 33 U.K. ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 34 U.K. ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 35 U.K. Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 36 U.K. Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 37 Germany Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 38 Germany IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 39 Germany IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 40 Germany ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 41 Germany ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 42 Germany Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 43 Germany Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 44 France Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 45 France IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 46 France IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 47 France ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 48 France ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 49 France Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 50 France Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 51 Spain Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 52 Spain IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 53 Spain IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 54 Spain ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 55 Spain ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 56 Spain Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 57 Spain Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 58 Italy Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 59 Italy IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 60 Italy IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 61 Italy ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 62 Italy ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 63 Italy Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 64 Italy Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 65 Asia Pacific Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 66 Asia Pacific IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 67 Asia Pacific IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 68 Asia Pacific ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 69 Asia Pacific ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 70 Asia Pacific Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 71 Asia Pacific Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 72 Japan Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 73 Japan IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 74 Japan IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 75 Japan ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 76 Japan ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 77 Japan Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 78 Japan Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 79 China Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 80 China IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 81 China IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 82 China ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 83 China ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 84 China Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 85 China Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 86 India Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 87 India IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 88 India IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 89 India ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 90 India ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 91 India Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 92 India Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 93 South Korea Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 94 South Korea IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 95 South Korea IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 96 South Korea ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 97 South Korea ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 98 South Korea Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 99 South Korea Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 100 Singapore Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 101 Singapore IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 102 Singapore IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 103 Singapore ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 104 Singapore ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 105 Singapore Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 106 Singapore Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 107 Australia Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 108 Australia IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 109 Australia IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 110 Australia ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 111 Australia ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 112 Australia Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 113 Australia Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 114 Latin America Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 115 Latin America IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 116 Latin America IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 117 Latin America ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 118 Latin America ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 119 Latin America Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 120 Latin America Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 121 Brazil Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 122 Brazil IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 123 Brazil IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 124 Brazil ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 125 Brazil ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 126 Brazil Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 127 Brazil Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 128 Mexico Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 129 Mexico IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 130 Mexico IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 131 Mexico ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 132 Mexico ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 133 Mexico Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 134 Mexico Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 135 Argentina Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 136 Argentina IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 137 Argentina IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 138 Argentina ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 139 Argentina ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 140 Argentina Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 141 Argentina Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 142 MEA Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 143 MEA IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 144 MEA IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 145 MEA ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 146 MEA ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 147 MEA Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 148 MEA Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 149 South Africa Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 150 South Africa IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 151 South Africa IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 152 South Africa ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 153 South Africa ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 154 South Africa Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 155 South Africa Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 156 UAE Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 157 UAE IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 158 UAE IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 159 UAE ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 160 UAE ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 161 UAE Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 162 UAE Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 163 Saudi Arabia Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 164 Saudi Arabia IR Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 165 Saudi Arabia IR Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 166 Saudi Arabia ER Opioids Market Estimates and Forecasts, By Product, 2014 - 2026 (USD Billion)
  • TABLE 167 Saudi Arabia ER Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 168 Saudi Arabia Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)
  • TABLE 169 Saudi Arabia Pain Relief Opioids Market Estimates and Forecasts, By Application, 2014 - 2026 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain based sizing & forecasting
  • FIG. 4 QFD modeling for market share assessment
  • FIG. 5 Market summary
  • FIG. 6 Market trends &outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market driver relevance analysis (Current & future impact)
  • FIG. 9 Market restraint relevance analysis (Current & future impact)
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 SWOT analysis, by Factor (political & legal, economic and technological)
  • FIG. 12 Porter's five forces analysis
  • FIG. 13 Global opioids market product outlook
  • FIG. 14 Global opioids market: Product movement analysis
  • FIG. 15 Immediate-release/Short-acting opioid market, 2014 - 2026 (USD Billion)
  • FIG. 16 Codeine market, 2014 - 2026 (USD Billion)
  • FIG. 17 Oxycodone market, 2014 - 2026 (USD Billion)
  • FIG. 18 Hydrocodone market, 2014 - 2026 (USD Billion)
  • FIG. 19 Fentanyl market, 2014 - 2026 (USD Billion)
  • FIG. 20 Morphine market, 2014 - 2026 (USD Billion)
  • FIG. 21 Hydroxymorphone market, 2014 - 2026 (USD Billion)
  • FIG. 22 Oxymorphone market, 2014 - 2026 (USD Billion)
  • FIG. 23 Propoxyphene market, 2014 - 2026 (USD Billion)
  • FIG. 24 Other IR market, 2014 - 2026 (USD Billion)
  • FIG. 25 Extended-release/Long-acting opioid market, 2014 - 2026 (USD Billion)
  • FIG. 26 Oxycodone market, 2014 - 2026 (USD Billion)
  • FIG. 27 Hydrocodone market, 2014 - 2026 (USD Billion)
  • FIG. 28 Methadone market, 2014 - 2026 (USD Billion)
  • FIG. 29 Fentanyl market, 2014 - 2026 (USD Billion)
  • FIG. 30 Morphine market, 2014 - 2026 (USD Billion)
  • FIG. 31 Oxymorphone market, 2014 - 2026 (USD Billion)
  • FIG. 32 Tapentadol market, 2014 - 2026 (USD Billion)
  • FIG. 33 Buprenorphine market, 2014 - 2026 (USD Billion)
  • FIG. 34 Hydromorphone market, 2014 - 2026 (USD Billion)
  • FIG. 35 Other ER market, 2014 - 2026 (USD Billion)
  • FIG. 36 Global opioids Market application outlook key takeaways
  • FIG. 37 Global opioids market: Application movement analysis
  • FIG. 38 Pain relief market, 2014 - 2026 (USD Billion)
  • FIG. 39 Cancer pain market, 2014 - 2026 (USD Billion)
  • FIG. 40 Postoperative pain management market, 2014 - 2026 (USD Billion)
  • FIG. 41 Low back pain market, 2014 - 2026 (USD Billion)
  • FIG. 42 Orthopedic market, 2014 - 2026 (USD Billion)
  • FIG. 43 Neuropathic pain market, 2014 - 2026 (USD Billion)
  • FIG. 44 Fibromyalgia market, 2014 - 2026 (USD Billion)
  • FIG. 45 Anesthesia market, 2014 - 2026 (USD Billion)
  • FIG. 46 Cough suppression market, 2014 - 2026 (USD Billion)
  • FIG. 47 Diarrhea suppression market, 2014 - 2026 (USD Billion)
  • FIG. 48 De-addiction market, 2014 - 2026 (USD Billion)
  • FIG. 49 Regional market place: Key takeaways
  • FIG. 50 Regional outlook, 2018 & 2026
  • FIG. 51 North America opioids market, 2014 - 2026 (USD Billion)
  • FIG. 52 U.S. opioids market, 2014 - 2026 (USD Billion)
  • FIG. 53 Canada opioids market, 2014 - 2026 (USD Billion)
  • FIG. 54 Europe opioids market, 2014 - 2026 (USD Billion)
  • FIG. 55 U.K. opioids market, 2014 - 2026 (USD Billion)
  • FIG. 56 Germany opioids market, 2014 - 2026 (USD Billion)
  • FIG. 57 France opioids market, 2014 - 2026 (USD Billion)
  • FIG. 58 Spain opioids market, 2014 - 2026 (USD Billion)
  • FIG. 59 Italy opioids market, 2014 - 2026 (USD Billion)
  • FIG. 60 Asia Pacific opioids market, 2014 - 2026 (USD Billion)
  • FIG. 61 Japan opioids market, 2014 - 2026 (USD Billion)
  • FIG. 62 China opioids market, 2014 - 2026 (USD Billion)
  • FIG. 63 India opioids market, 2014 - 2026 (USD Billion)
  • FIG. 64 Australia opioids market, 2014 - 2026 (USD Billion)
  • FIG. 65 South Korea opioids market, 2014 - 2026 (USD Billion)
  • FIG. 66 Singapore opioids market, 2014 - 2026 (USD Billion)
  • FIG. 67 Latin America opioids market, 2014 - 2026 (USD Billion)
  • FIG. 68 Brazil opioids market, 2014 - 2026 (USD Billion)
  • FIG. 69 Mexico opioids market, 2014 - 2026 (USD Billion)
  • FIG. 70 Argentina opioids market, 2014 - 2026 (USD Billion)
  • FIG. 71 MEA opioids market, 2014 - 2026 (USD Billion)
  • FIG. 72 South Africa opioids market, 2014 - 2026 (USD Billion)
  • FIG. 73 UAE opioids market, 2014 - 2026 (USD Billion)
  • FIG. 74 Saudi Arabia opioids market, 2014 - 2026 (USD Billion)
  • FIG. 75 Strategy framework
  • FIG. 76 Participant categorization
目次
Product Code: GVR-2-68038-131-3

The global opioids market size is estimated to reach USD 29.4 billion by 2026, according to a new report by Grand View Research, Inc., expanding at a CAGR of 1.8% over the forecast period. Growing geriatric population, coupled with increasing focus on palliative care, is estimated to drive the market. Moreover, increasing geographical expansions by market players is expected to fuel growth.

Rising prevalence of disease conditions with chronic pain, such as cancer, lower back pain, arthritis, and fibromyalgia, is driving the opioids market. Substantial rise in road accidents and trauma, coupled with constantly increasing cases of surgical procedures, is also driving demand for opioid-based pain management solutions.

On the basis of product, ER was the dominant segment in 2018 owing to its high usage in chronic pain management. However, the abuse and misuse of these drugs have resulted in a serious public health crisis.

North America led the market in 2018 with a share of 55.5% in terms of revenue. One of the major reasons for its dominance is rising geriatric population with terminal conditions, such as rheumatoid arthritis. However, opioid abuse in U.S. has been rising at an alarming rate. Overdose has killed over 28,000 people in 2014 alone. Almost half of those deaths were caused by prescription drugs. Hence, drug abuse has been declared a "public health emergency" in U.S. and this is likely to limit market growth in North America.

According to the federal government, around 4,000 Canadians died due to opioid-related overdose in 2017, which is a 34% jump from the previous year. Globally, Canadians are one of the highest users of prescription opioids and this rate, along with associated deaths and hospital visits, has been growing rapidly. To combat this, Health Canada aims to restrict the marketing of such drugs.

The federal government is calling on pharmaceutical companies to stop marketing opioids. For instance, Purdue Pharma has stopped marketing its opioids in Canada, thereby limiting the growth of the North America market. The company has, in fact, shifted its focus to other regions, such as Asia Pacific, to retain its hold in the market. APAC is likely to witness the fastest growth in the coming years.

Further key findings from the study suggest:

Extended release was the largest product segment in 2018 due to its high usage in chronic pain management

Cancer pain was the largest pain relief segment in 2018 owing to global increase in prevalence of cancer

North America was the largest regional market in 2018, driven by presence of key players and highest use of prescription opioids

Europe was the second-largest regional market in 2018, primarily fueled by growing geriatric population

Asia Pacific is expected to witness the fastest growth over the forecast period due to increase in geriatric population, coupled with shifting focus of key players towards this region in order to strengthen their position

Some of the key players are Purdue Pharma L.P; West-Ward Pharmaceuticals Corporation; Allergan; Pfizer, Inc.; Janssen Pharmaceuticals, Inc.; Egalet Corporation; and Sun Pharmaceutical Industries Limited. Most key players are focusing on entering untapped regions and expanding their product portfolios.

Table of Contents

Chapter 1 Methodology and Scope

      • 1.1.Market Segmentation & scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third party perspectives
    • 1.3.4. Primary research
  • 1.4. Information Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Opioids Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Regulatory Framework
    • 3.2.1. Reimbursement framework
    • 3.2.2. Standards & compliances
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Expanding application of opioids in various therapeutic conditions
      • 3.3.1.2. Expanding target audience for the opioid market
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Stringent regulatory framework
      • 3.3.2.2 Opioid abuse and dependency
  • 3.4. Global Opioids Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power: (Low due to government control on pricing)
      • 3.4.1.2. Buyer power: (High due to availability of wide-range of generic products)
      • 3.4.1.3. Substitution threat: (High due to highly regulated supply of opioids)
      • 3.4.1.4. Threat from new entrant: (Low due to strict regulations and guidelines)
      • 3.4.1.5. Competitive rivalry: (Moderate due to presence of few key players)
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Environmental landscape
      • 3.4.2.3. Social landscape
      • 3.4.2.4. Technology landscape
      • 3.4.2.5. Legal landscape
    • 3.4.3. Major deals & strategic alliances analysis
      • 3.4.3.1. Joint ventures
      • 3.4.3.2. Mergers & acquisitions
      • 3.4.3.3. Licensing & partnership
      • 3.4.3.4. Technology collaborations
      • 3.4.3.5. Strategic divestments

Chapter 4. Global Opioids Market - Competitive Analysis

  • 4.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.3. Vendor Landscape
    • 4.3.1. List of key distributors and channel partners
    • 4.3.2. Key company market share analysis, 2018
  • 4.4. Public Companies
    • 4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.4.2. Company market share
    • 4.4.3. Competitive dashboard analysis
    • 4.4.4. Market differentiators
    • 4.4.5. Synergy analysis: Major deals & strategic alliances
  • 4.5. Private Companies
    • 4.5.1. List of key emerging companies
    • 4.5.2. Regional network map
    • 4.5.3. Company market position analysis (Geographic presence, product portfolio, key alliance, industry experience)

Chapter 5. Global Opioids Market: Product Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Product Market Share Analysis, 2018 & 2026
  • 5.3. Global Opioids Market, by Product, 2014 to 2026
  • 5.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the Following,
    • 5.4.1. Immediate-release/Short-acting opioid
      • 5.4.1.1 Immediate-release/Short-acting opioid market, 2014 - 2026 (USD Billion)
      • 5.4.1.2 Codeine
      • 5.4.1.2.1 Codeine market, 2014 - 2026 (USD Billion)
      • 5.4.1.3 Oxycodone
      • 5.4.1.3.1 Oxycodone market, 2014 - 2026 (USD Billion)
      • 5.4.1.4 Hydrocodone
      • 5.4.1.4.1 Hydrocodone market, 2014 - 2026 (USD Billion)
      • 5.4.1.5 Fentanyl
      • 5.4.1.5.1 Fentanyl market, 2014 - 2026 (USD Billion)
      • 5.4.1.6 Morphine
      • 5.4.1.6.1 Morphine market, 2014 - 2026 (USD Billion)
      • 5.4.1.7 Hydroxymorphone
      • 5.4.1.7.1 Hydroxymorphone market, 2014 - 2026 (USD Billion)
      • 5.4.1.8 Oxymorphone
      • 5.4.1.8.1 Oxymorphone market, 2014 - 2026 (USD Billion)
      • 5.4.1.9 Propoxyphene
      • 5.4.1.9.1 Propoxyphene market, 2014 - 2026 (USD Billion)
      • 5.4.1.10 Others
      • 5.4.1.10.1 Others market, 2014 - 2026 (USD Billion)
    • 5.4.2. Extended-release/Long-acting opioid
      • 5.4.2.1 Extended-release/Long-acting opioid market, 2014 - 2026 (USD Billion)
      • 5.4.2.2 Oxycodone
      • 5.4.2.2.1 Oxycodone market, 2014 - 2026 (USD Billion)
      • 5.4.2.3 Hydrocodone
      • 5.4.2.3.1 Hydrocodone market, 2014 - 2026 (USD Billion)
      • 5.4.2.4 Methadone
      • 5.4.2.4.1 Methadone market, 2014 - 2026 (USD Billion)
      • 5.4.2.5 Fentanyl
      • 5.4.2.5.1 Fentanyl market, 2014 - 2026 (USD Billion)
      • 5.4.2.6 Morphine
      • 5.4.2.6.1 Morphine market, 2014 - 2026 (USD Billion)
      • 5.4.2.7 Oxymorphone
      • 5.4.2.7.1 Oxymorphone market, 2014 - 2026 (USD Billion)
      • 5.4.2.8 Tapentadol
      • 5.4.2.8.1 Tapentadol market, 2014 - 2026 (USD Billion)
      • 5.4.2.9 Buprenorphine
      • 5.4.2.9.1 Buprenorphine market, 2014 - 2026 (USD Billion)
      • 5.4.2.10 Hydromorphone
      • 5.4.2.10.1 Hydromorphone market, 2014 - 2026 (USD Billion)
      • 5.4.2.11 Others
      • 5.4.2.11.1 Others market, 2014 - 2026 (USD Billion)
  • 5.5. Product Markets, by Application, 2014 to 2026:
    • 5.5.1. Immediate-release/Short-acting opioid
      • 5.5.1.1 Pain relief
      • 5.5.1.1.1 Pain relief market, 2014 - 2026 (USD Billion)
      • 5.5.1.2 Anesthesia
      • 5.5.1.2.1 Anesthesia market, 2014 - 2026 (USD Billion)
      • 5.5.1.3 Cough suppression
      • 5.5.1.3.1 Cough suppression market, 2014 - 2026 (USD Billion)
      • 5.5.1.4 Diarrhea
      • 5.5.1.4.1 Diarrhea market, 2014 - 2026 (USD Billion)
      • 5.5.1.5 De-addiction
      • 5.5.1.5.1 De-addiction market, 2014 - 2026 (USD Billion)
    • 5.5.2. Extended-release/Long-acting opioid
      • 5.5.2.1 Pain relief
      • 5.5.2.1.1 Pain relief market, 2014 - 2026 (USD Billion)
      • 5.5.2.2 Anesthesia
      • 5.5.2.2.1 Anesthesia market, 2014 - 2026 (USD Billion)
      • 5.5.2.3 Cough suppression
      • 5.5.2.3.1 Cough suppression market, 2014 - 2026 (USD Billion)
      • 5.5.2.4 Diarrhea
      • 5.5.2.4.1 Diarrhea market, 2014 - 2026 (USD Billion)
      • 5.5.2.5 De-addiction
      • 5.5.2.5.1 De-addiction market, 2014 - 2026 (USD Billion)

Chapter 6. Global Opioids Market: Application Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Application Market Share Analysis, 2018 & 2026
  • 6.3. Global Opioids Market, by Application, 2014 to 2026
  • 6.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the Following,
    • 6.4.1. Pain relief
      • 6.4.1.1 Pain relief market, 2014 - 2026 (USD Billion)
      • 6.4.1.2 Cancer pain
      • 6.4.1.2.1 Cancer pain market, 2014 - 2026 (USD Billion)
      • 6.4.1.3 Postoperative pain
      • 6.4.1.3.1 Postoperative pain market, 2014 - 2026 (USD Billion)
      • 6.4.1.4 Low back pain
      • 6.4.1.4.1 Low back pain market, 2014 - 2026 (USD Billion)
      • 6.4.1.5 Orthopedic
      • 6.4.1.5.1 Orthopedic market, 2014 - 2026 (USD Billion)
      • 6.4.1.6 Neuropathic pain
      • 6.4.1.6.1 Neuropathic pain market, 2014 - 2026 (USD Billion)
      • 6.4.1.7 Fibromyalgia
      • 6.4.1.7.1 Fibromyalgia market, 2014 - 2026 (USD Billion)
    • 6.4.2. Anesthesia
      • 6.4.2.1 Anesthesia market, 2014 - 2026 (USD Billion)
    • 6.4.3. Cough suppression
      • 6.4.3.1 Cough suppression market, 2014 - 2026 (USD Billion)
    • 6.4.4. Diarrhea suppression
      • 6.4.4.1 Diarrhea suppression market, 2014 - 2026 (USD Billion)
    • 6.4.5. De-addiction
      • 6.4.5.1 De-addiction market, 2014 - 2026 (USD Billion)

Chapter 7 Global Opioids Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, & End-use

  • 7.1 Global Opioids Market: Regional Movement Analysis, 2018 & 2026
  • 7.2 Global Opioids Market: Leading Players, 2018:
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4 North America
    • 7.4.1 North America opioids market, 2014 - 2026 (USD Billion)
    • 7.4.2 U.S.
      • 7.4.2.1 U.S. opioids market, 2014 - 2026 (USD Billion)
    • 7.4.3 Canada
      • 7.4.3.1 Canada opioids narket, 2014 - 2026 (USD Billion)
  • 7.5. Europe
    • 7.5.1 Europe opioids market, 2014 - 2026 (USD Billion)
    • 7.5.2 U.K.
      • 7.5.2.1 U.K. opioids market, 2014 - 2026 (USD Billion)
    • 7.5.3 Germany
      • 7.5.3.1 Germany opioids market, 2014 - 2026 (USD Billion)
    • 7.5.4 France
      • 7.5.4.1 France opioids market, 2014 - 2026 (USD Billion)
    • 7.5.5 Spain
      • 7.5.5.1 Spain opioids market, 2014 - 2026 (USD Billion)
    • 7.5.6 Italy
      • 7.5.6.1 Italy opioids market, 2014 - 2026 (USD Billion)
  • 7.6 Asia Pacific
    • 7.6.1 Asia Pacific opioids market, 2014 - 2026 (USD Billion)
    • 7.6.2 Japan
      • 7.6.2.1 Japan opioids market, 2014 - 2026 (USD Billion)
    • 7.6.3 China
      • 7.6.3.1 China opioids market, 2014 - 2026 (USD Billion)
    • 7.6.4 India
      • 7.6.4.1 India opioids market, 2014 - 2026 (USD Billion)
    • 7.6.5 South Korea
      • 7.6.5.1 South Korea opioids market, 2014 - 2026 (USD Billion)
    • 7.6.6 Singapore
      • 7.6.6.1 Singapore opioids market, 2014 - 2026 (USD Billion)
    • 7.6.7 Australia
      • 7.6.7.1 Australia opioids market, 2014 - 2026 (USD Billion)
  • 7.7 Latin America
    • 7.7.1 Latin America opioids market, 2014 - 2026 (USD Billion)
    • 7.7.2 Brazil
      • 7.7.2.1 Brazil opioids market, 2014 - 2026 (USD Billion)
    • 7.7.3 Mexico
      • 7.7.3.1 Mexico opioids market, 2014 - 2026 (USD Billion)
    • 7.7.4 Argentina
      • 7.7.4.1 Argentina opioids market, 2014 - 2026 (USD Billion)
  • 7.8 MEA
    • 7.8.1 MEA opioids market, 2014 - 2026 (USD Billion)
    • 7.8.2 South Africa
      • 7.8.2.1 South Africa opioids market, 2014 - 2026 (USD Billion)
    • 7.8.3 United Arab Emirates
      • 7.8.3.1 United Arab Emirates opioids market, 2014 - 2026 (USD Billion)
    • 7.8.4 Saudi Arabia
      • 7.8.4.1 Saudi Arabia opioids market, 2014 - 2026 (USD Billion)

Chapter 8 Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Heat Map Analysis of Private Companies
    • 8.2.1 Company size
    • 8.2.2 Distribution network
    • 8.2.3 Product portfolio
    • 8.2.4 Segment coverage
    • 8.2.5 Geographic presence
    • 8.2.6 Collaborations
    • 8.2.7 Conclusion
  • 8.3 Purdue Pharma L.P
    • 8.3.1 Company overview
    • 8.3.2 Financial performance
    • 8.3.3 Product benchmarking
    • 8.3.4 Strategic initiatives
  • 8.4 Janssen Pharmaceuticals, Inc.
    • 8.4.1 Company overview
    • 8.4.2 Financial performance
    • 8.4.3 Product benchmarking
    • 8.4.4 Strategic initiatives
  • 8.5 West-Ward Pharmaceuticals Corporation
    • 8.5.1 Company overview
    • 8.5.2 Financial performance
    • 8.5.3 Product benchmarking
    • 8.5.4 Strategic initiatives
  • 8.6 Pfizer, Inc.
    • 8.6.1 Company overview
    • 8.6.2 Financial performance
    • 8.6.3 Product benchmarking
    • 8.6.4 Strategic initiatives
  • 8.7 ALLERGAN (Actavis)
    • 8.7.1 Company overview
    • 8.7.2 Financial performance
    • 8.7.3 Product benchmarking
    • 8.7.4 Strategic initiatives
  • 8.8 Sanofi-Aventis S.A.
    • 8.8.1 Company overview
    • 8.8.2 Financial performance
    • 8.8.3 Product benchmarking
    • 8.8.4 Strategic initiatives
  • 8.9 Sun Pharmaceutical Industries Limited
    • 8.9.1 Company overview
    • 8.9.2 Financial performance
    • 8.9.3 Product benchmarking
    • 8.9.4 Strategic initiatives
  • 8.10 Grunenthal GmbH
    • 8.10.1 Company overview
    • 8.10.2 Financial performance
    • 8.10.3 Product benchmarking
    • 8.10.4 Strategic initiatives
Back to Top